These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22889124)

  • 41. Potential treatment of atopic dermatitis: tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects.
    Siddique MI; Katas H; Jamil A; Mohd Amin MCI; Ng SF; Zulfakar MH; Nadeem SM
    Drug Deliv Transl Res; 2019 Apr; 9(2):469-481. PubMed ID: 29159691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
    Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
    Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amphiphilic methoxy poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(2-dimethylaminoethyl methacrylate) cationic copolymer nanoparticles as a vector for gene and drug delivery.
    Yue X; Qiao Y; Qiao N; Guo S; Xing J; Deng L; Xu J; Dong A
    Biomacromolecules; 2010 Sep; 11(9):2306-12. PubMed ID: 20666510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery.
    Chen J; Li S; Shen Q
    Eur J Pharm Sci; 2012 Sep; 47(2):430-43. PubMed ID: 22796217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model.
    Ma G; Yang J; Zhang L; Song C
    Anticancer Drugs; 2010 Mar; 21(3):261-9. PubMed ID: 20016371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and Characterization of Chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line.
    Eatemadi A; Daraee H; Aiyelabegan HT; Negahdari B; Rajeian B; Zarghami N
    Biomed Pharmacother; 2016 Dec; 84():1915-1922. PubMed ID: 27847208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer.
    Cuong NV; Hsieh MF; Chen YT; Liau I
    J Biomater Sci Polym Ed; 2011; 22(11):1409-26. PubMed ID: 20594418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
    Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
    Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
    Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
    J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles.
    Zhu Z; Xie C; Liu Q; Zhen X; Zheng X; Wu W; Li R; Ding Y; Jiang X; Liu B
    Biomaterials; 2011 Dec; 32(35):9525-35. PubMed ID: 21903260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel.
    Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z
    J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.
    Mohammadi G; Nokhodchi A; Barzegar-Jalali M; Lotfipour F; Adibkia K; Ehyaei N; Valizadeh H
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):39-44. PubMed ID: 21752610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the physical-chemical properties and stability of dapivirine-loaded polymeric nanoparticles.
    das Neves J; Amiji M; Bahia MF; Sarmento B
    Int J Pharm; 2013 Nov; 456(2):307-14. PubMed ID: 24012910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
    Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
    Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.